Hubin Yin

1.2k total citations
29 papers, 886 citations indexed

About

Hubin Yin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Hubin Yin has authored 29 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Epidemiology. Recurrent topics in Hubin Yin's work include Autophagy in Disease and Therapy (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Epigenetics and DNA Methylation (5 papers). Hubin Yin is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Epigenetics and DNA Methylation (5 papers). Hubin Yin collaborates with scholars based in China and United States. Hubin Yin's co-authors include Xin Gou, Weiyang He, Gongmin Zhu, Lin Fan, Xinyuan Li, Weiyang He, Hang Tong, Lijiao Pei, Nian Liu and Ning Xu and has published in prestigious journals such as The FASEB Journal, Journal of Cellular Physiology and BioMed Research International.

In The Last Decade

Hubin Yin

28 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hubin Yin China 18 613 377 155 151 149 29 886
Yuanjun Jiang China 18 365 0.6× 175 0.5× 111 0.7× 66 0.4× 88 0.6× 47 734
Jin Hyung Heo South Korea 16 528 0.9× 374 1.0× 56 0.4× 62 0.4× 121 0.8× 38 860
Qiuxia Cui China 17 414 0.7× 213 0.6× 190 1.2× 41 0.3× 143 1.0× 38 807
Binhui Ren China 17 568 0.9× 394 1.0× 130 0.8× 33 0.2× 135 0.9× 33 848
Rachana Sainger United States 16 352 0.6× 108 0.3× 226 1.5× 118 0.8× 102 0.7× 26 928
Wen Ni China 12 884 1.4× 730 1.9× 83 0.5× 45 0.3× 78 0.5× 18 1.2k
Limin Zhai China 16 448 0.7× 350 0.9× 53 0.3× 75 0.5× 82 0.6× 33 763
Dingyuan Jiang China 15 374 0.6× 203 0.5× 350 2.3× 93 0.6× 81 0.5× 31 854
Ida Katrine Lund Denmark 18 335 0.5× 356 0.9× 90 0.6× 39 0.3× 83 0.6× 43 839

Countries citing papers authored by Hubin Yin

Since Specialization
Citations

This map shows the geographic impact of Hubin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubin Yin more than expected).

Fields of papers citing papers by Hubin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubin Yin. The network helps show where Hubin Yin may publish in the future.

Co-authorship network of co-authors of Hubin Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Hubin Yin. A scholar is included among the top collaborators of Hubin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubin Yin. Hubin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Hang, Yan Sun, Junlong Zhu, et al.. (2025). Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 265–265.
2.
Yu, Haitao, Chunlin Zhang, Xuesong Bai, et al.. (2024). Identifying endoplasmic reticulum stress-related genes as new diagnostic and prognostic biomarkers in clear cell renal cell carcinoma. Translational Andrology and Urology. 13(1). 1–24. 2 indexed citations
3.
Wu, Linfeng, Yan Sun, Junlong Zhu, et al.. (2024). Nucleolar protein 3 promotes proliferation of bladder cancer cells through the PI3K-Akt pathway. World Journal of Surgical Oncology. 22(1). 316–316. 1 indexed citations
4.
Sun, Yan, Xudong Liu, Hang Tong, et al.. (2023). SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy. Cancers. 16(1). 125–125. 10 indexed citations
5.
Yin, Hubin, Chen Zhang, Zongjie Wei, et al.. (2022). EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation. Cell Death and Disease. 13(1). 39–39. 17 indexed citations
6.
Tong, Hang, et al.. (2021). Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming. Cancer Cell International. 21(1). 597–597. 27 indexed citations
7.
Xu, Ning, Yu‐Peng Wu, Hubin Yin, et al.. (2020). SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis. Journal of Cancer Research and Clinical Oncology. 146(8). 1953–1969. 23 indexed citations
8.
Zhu, Xin, Hang Tong, Hubin Yin, et al.. (2020). C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients. BioMed Research International. 2020(1). 7139721–7139721. 6 indexed citations
9.
Yin, Hubin, et al.. (2020). <p>Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway</p>. OncoTargets and Therapy. Volume 13. 813–825. 24 indexed citations
10.
Zhang, Chen, et al.. (2020). A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer. Cancer Cell International. 20(1). 177–177. 28 indexed citations
11.
Yang, Guang, Hubin Yin, Lin Fan, et al.. (2020). Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis. Pathology - Research and Practice. 216(4). 152851–152851. 19 indexed citations
12.
Zhu, Gongmin, Lijiao Pei, Lin Fan, et al.. (2019). Exosomes from human‐bone‐marrow‐derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR‐199a‐3p. Journal of Cellular Physiology. 234(12). 23736–23749. 126 indexed citations
13.
Fan, Lin, et al.. (2019). Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression. International Journal of Oncology. 56(1). 151–164. 107 indexed citations
14.
Zhang, Chen, Na Li, Xueqing Liu, et al.. (2019). Elevated insulin levels compromise endometrial decidualization in mice with decrease in uterine apoptosis in early-stage pregnancy. Archives of Toxicology. 93(12). 3601–3615. 29 indexed citations
15.
Zhu, Gongmin, Lijiao Pei, Hubin Yin, et al.. (2019). Profiles of tumor‑infiltrating immune cells in renal cell carcinoma and their clinical implications. Oncology Letters. 18(5). 5235–5242. 22 indexed citations
16.
Xu, Ning, Yu‐Peng Wu, Hubin Yin, Xue‐Yi Xue, & Xin Gou. (2018). Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer. Journal of Translational Medicine. 16(1). 274–274. 42 indexed citations
17.
18.
Yin, Hubin, Weiyang He, Yunhai Li, et al.. (2018). Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer. Human Pathology. 85. 152–161. 17 indexed citations
19.
Huang, Xiaolong, Hao Zhang, Xiaoyu Yang, et al.. (2017). Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells. Anti-Cancer Drugs. 28(6). 596–602. 18 indexed citations
20.
Shen, Qin, et al.. (2000). Association between cigarette smoking and FHIT gene alterations in Chinese lung cancer. Lung Cancer. 29(1). 235–235. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanjun Jiang Breakdown of academic impact, for papers by Jin Hyung Heo Breakdown of academic impact, for papers by Qiuxia Cui Breakdown of academic impact, for papers by Binhui Ren Breakdown of academic impact, for papers by Rachana Sainger Breakdown of academic impact, for papers by Wen Ni Breakdown of academic impact, for papers by Limin Zhai Breakdown of academic impact, for papers by Dingyuan Jiang Breakdown of academic impact, for papers by Ida Katrine Lund
Rankless by CCL
2026